Last reviewed · How we verify
NCT04647305: COVPROSHIELD
Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission
NA trial testing Closed face shield with Surgical face mask use in SARS-CoV-2 Infection in 233 participants. Completed in 4 March 2021.
4 March 2021
Quick facts
| Lead sponsor | University of Los Andes, Columbia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 233 |
| Start date | 16 January 2021 |
| Primary completion | 4 March 2021 |
| Estimated completion | 4 March 2021 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Closed face shield with Surgical face mask use
- Surgical face mask use only
Conditions studied
- SARS-CoV-2 Infection — all drugs for SARS-CoV-2 Infection →
Sponsor
University of Los Andes, Columbia
Who can join
18 and older, any sex, with SARS-CoV-2 Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A non-inferiority randomized controlled trial that aims to determine the effectiveness and adherence of the use of closed-face shields and surgical face masks in comparison with the use of surgical face masks for the prevention of SARS-CoV-2 infection in working adults in the city of Bogota, Colombia.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review.
Hirt J, Janiaud P, Hemkens LG. · · 2022 · cited 24× · PMID 35086864 · DOI 10.1136/bmjebm-2021-111825 -
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, et al · · 2022 · cited 17× · PMID 35514111 · DOI 10.1002/14651858.cd015112.pub2 -
Effectiveness and adherence to closed face shields in the prevention of COVID-19 transmission: a non-inferiority randomized controlled trial in a middle-income setting (COVPROSHIELD).
Varela AR, Gurruchaga AP, Restrepo SR, Martin JD, et al · · 2022 · cited 5× · PMID 35987694 · DOI 10.1186/s13063-022-06606-0 -
Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis
Hirt J, Janiaud P, Hemkens LG. · · 2021 · DOI 10.1101/2021.08.20.21261687
Verify or expand the search:
- PubMed search for NCT04647305
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV-2 Infection
Currently open trials in the same condition.
- NCT07079670 — Safety and Immunogenicity of NVX-CoV2705 · Phase 3 · active not recruiting
- NCT05697068 — Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos · NA · active not recruiting
- NCT05172011 — Understanding the Long-term Impact of COVID on Children and Families · active not recruiting
- NCT05141058 — T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients · Phase 1 · recruiting
- NCT05046470 — SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study · active not recruiting
Other University of Los Andes, Columbia trials
Trials by the same sponsor.
- NCT07148531 — Caregiver Mental Health and Early Childhood Development in Conflict-Affected Settings · NA · active not recruiting
- NCT06579456 — Evaluation in a Multimodal Structured Curriculum of Laparoscopic Surgery · NA · completed
- NCT04647318 — Physiological Response to Self-compassion Versus Relaxation · NA · completed
- NCT03512665 — Evaluation of the Impact of a Nutritional Supplement Made of Vegetable Oils in People at Risk of Diabetes · NA · completed
- NCT03502252 — Experimental Evaluation of Semillas de Apego · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04647305 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Los Andes, Columbia
- Last refreshed: 27 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04647305.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing